Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 

Siena, Proteome to provide protein, peptide biomarker services
September 2011
SHARING OPTIONS:

SIENA, Italy—Siena Biotech, a clinical-stage drug discovery company based in Siena, Italy, recently announced that under a master research agreement, the company has retained Proteome Sciences as its preferred supplier of protein and peptide biomarker services for its drug development programs. Under the agreement, Proteome can apply its PS Biomarker Services to provide a detailed analysis of post-translational modifications on a neurological disease-related protein. In addition, Proteome will perform mass spectrometry analysis on proteins of interest to Siena and is expected to apply sample preparation and analytical methods combined with Orbitrap Velos mass spectrometry to provide a PTM map of Siena's protein target.

Christopher Pearce, CEO of Proteome, noted in a press release that through the use of Tandem Mass Tags, the companies can develop targeted mass spectrometry assays for use in clinical trials as well as routine medicine.


 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.